15 completed, 3 withdrawn, 1 terminated. 6 Phase 2, 5 Not applicable, 4 Phase 1, 4 Phase 3, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Terminated 1 |
| Not applicable | 5 | Completed 3, Withdrawn 2 |
| Phase 1 | 4 | Completed 3, Terminated 1 |
| Phase 3 | 4 | Completed 3, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Ginkgo biloba: new trials by email Literature Review of Ginkgo biloba trials Research Report on Ginkgo biloba
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-term Oral Prednisone for Acute Subjective Tinnitus Prednisone tablet, Ginkgo Biloba Extract - Tinnitus, Subjective | Not applicable | Completed | Eye & ENT Hospital of Fudan University | 146 | 2022-10-30 | 2025-02-28 |
| Different Treatment Options Used for Post Covid-19 Syndrome Ginkgo biloba, Piracetam, Ginkgo biloba and Piracetam - COVID-19, Post COVID-19 Syndrome | Not applicable | Completed | Beni-Suef University | 90 | 2021-02-01 | 2026-07-28 |
| ROTEM and Dietary Supplements Ginger, Garlic, Ginkgo Biloba - Dietary Supplements, Bleeding Tendency; Due to Coagulation Defect | Not applicable | Withdrawn | University of Pretoria | 2017-06-01 | 2018-05-09 | |
| Cognitive and Blood Flow Effects of Mountain Tea Sideritis Scardica, Ginkgo biloba, Placebo control - Cognitive Change, Affect | Not applicable | Completed | Northumbria University | 155 | 2017-02-17 | 2018-03-23 |
| Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy Ginkgo biloba, modified TRT - Tinnitus | Not applicable | Withdrawn | Seoul National University Hospital | 2014-09-01 | 2016-10-25 | |
| The Efficacy of Steroid Therapy in Vestibular Neuritis Ginkgo biloba & Methylprednisolone, Ginkgo biloba - Vestibular Neuritis | Phase 3 | Completed | Asan Medical Center | 40 | 2014-03-01 | 2019-01-10 |
| Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity Placebo, Ginseng, Ginkgo Biloba - Blood Pressure, Cognition | Early Phase 1 | Completed | Sunway University | 48 | 2014-03-01 | 2015-03-13 |
| Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma Ginkgo biloba, Placebo to Ginkgo biloba - Glaucoma, Open-Angle | Phase 2 | Completed | Maisonneuve-Rosemont Hospital | 19 | 2011-08-01 | 2015-03-03 |
| Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI Ginkgo biloba - Mild Cognitive Impairment | Phase 4 | Completed | University Hospital, Basel, Switzerland | 50 | 2010-01-01 | 2015-10-14 |
| Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents Ginkgo biloba - Vitiligo Vulgaris | Phase 1 | Completed | University of Toronto | 12 | 2009-05-01 | 2010-07-08 |
| Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis Ginkgo biloba, Placebo - Multiple Sclerosis, Cognitive Ability, General | Phase 2 | Completed | US Department of Veterans Affairs | 120 | 2009-01-01 | 2014-06-06 |
| Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon Ginkgo biloba extract EGb 761 - Raynaud Disease | Phase 2 | Completed | VSM Geneesmiddelen b.v. | 41 | 2005-11-01 | 2017-05-22 |
| Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT) ginkgo biloba, matched placebo - Memory, Short-Term | Phase 1 / Phase 2 | Terminated | Medical University of South Carolina | 50 | 2003-02-01 | 2018-07-18 |
| EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer Ginkgo Biloba, Placebo - Breast Cancer, Neurotoxicity | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 226 | 2002-12-01 | 2016-07-06 |
| Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction Ginkgo Biloba, Sex Therapy (genital focus) - Hypoactive Sexual Desire Disorder, Sexual Dysfunctions, Psychological | Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 2002-06-01 | 2006-08-18 | |
| Effect of Ginkgo Biloba on Phenytoin Elimination Ginkgo Biloba - Healthy | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 12 | 2001-02-01 | 2008-03-04 |
| Ginkgo Biloba Prevention Trial in Older Individuals Ginkgo biloba, Placebo - Dementia, Alzheimer's Disease | Phase 3 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 3069 | 2000-10-01 | 2013-03-14 |
| Natural Antioxidants in the Treatment of Multiple Sclerosis Ginkgo biloba, Alpha-lipoic acid, Vitamin E/Selenium - Multiple Sclerosis | Phase 1 / Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 1999-09-01 | 2006-08-18 | |
| Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders Panax Ginseng + Ginkgo Biloba + Polyminerals + Multivitamin, Ginkgo Biloba (Tebonin®) - Memory Deficit | Phase 3 | Withdrawn | EMS | 2021-02-24 |
Multiple Sclerosis (2) · Tinnitus (2) · Alzheimer Disease (1) · Breast Neoplasms (1) · COVID-19 (1) · Cognitive Dysfunction (1) · Dementia (1) · Drug-Related Side Effects and Adverse Reactions (1) · Glaucoma (1) · Glaucoma, Open-Angle (1) · Hemostatic Disorders (1) · Memory Disorders (1) · Neurobehavioral Manifestations (1) · Neurotoxicity Syndromes (1) · Post-Acute COVID-19 Syndrome (1)
National Center for Complementary and Integrative Health (NCCIH) (3) · Alliance for Clinical Trials in Oncology (1) · Asan Medical Center (1) · Beni-Suef University (1) · EMS (1) · Eye & ENT Hospital of Fudan University (1) · Maisonneuve-Rosemont Hospital (1) · Medical University of South Carolina (1) · National Institutes of Health Clinical Center (CC) (1) · Northumbria University (1) · Seoul National University Hospital (1) · Sunway University (1) · US Department of Veterans Affairs (1) · University Hospital, Basel, Switzerland (1) · University of Pretoria (1)
United States (7) · Canada (2) · South Korea (2) · Brazil (1) · China (1) · Egypt (1) · Malaysia (1) · Netherlands (1) · Switzerland (1) · United Kingdom (1)
Charles H. Kellner, M.D. (1) · Cindy Meston, PhD (1) · Debra Barton, RN, PhD, AOCN, FAAN (1) · Dennis N. Bourdette, MD (1) · Dr. Dennis Bourdette (1) · Ellen Freeman, PhD (1) · Emma L Wightman, PhD (1) · Heather Boon, PhD (1) · Hong Ju Park, Professor (1) · Jayde V Wyngaard, MBCHB (1) · John S. Markowitz, PharmD (1) · Luca Aquili, PhD (1) · Mark Lesk, MD (1) · Orest Szczurko, ND MSc(cand) (1)
PMID 19017911, PMID 20040554, PMID 20123670, PMID 21406109, PMID 22955125, PMID 26938637, PMID 28093823, PMID 28391531
P50AT000066 (1), R21AT000939 (1), U01AT000162 (1)